Literature DB >> 29273307

Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.

Barbara Geppert1, Céline Lönnerfors1, Michele Bollino1, Jan Persson2.   

Abstract

OBJECTIVE: To compare the rate of lymphatic complications in women with endometrial cancer undergoing sentinel lymph node biopsy versus a full pelvic and infrarenal paraaortic lymphadenectomy, and to examine the overall feasibility and safety of the former.
METHODS: A prospective study of 188 patients with endometrial cancer planned for robotic surgery. Indocyanine green was used to identify the sentinel lymph nodes. In low-risk patients the lymphadenectomy was restricted to removal of sentinel lymph nodes whereas in high-risk patients also a full lymphadenectomy was performed. The impact of the extent of the lymphadenectomy on the rate of complications was evaluated.
RESULTS: The bilateral detection rate of sentinel lymph nodes was 96% after cervical tracer injection. No intraoperative complication was associated with the sentinel lymph node biopsy per se. Compared with hysterectomy alone, the additional average operative time for removal of sentinel lymph nodes was 33min whereas 91min were saved compared with a full pelvic and paraaortic lymphadenectomy. Sentinel lymph node biopsy alone resulted in a lower incidence of leg lymphedema than infrarenal paraaortic and pelvic lymphadenectomy (1.3% vs 18.1%, p=0.0003).
CONCLUSION: The high feasibility, the absence of intraoperative complications and the low risk of lymphatic complications supports implementing detection of sentinel lymph nodes in low-risk endometrial cancer patients. Given that available preliminary data on sensitivity and false negative rates in high-risk patients are confirmed in further studies, we also believe that the reduction in lymphatic complications and operative time strongly motivates the sentinel lymph node concept in high-risk endometrial cancer.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Chylous ascites; Endometrial cancer; Indocyanine green; Lymphadenectomy; Lymphatic metastases; Lymphatic system; Lymphedema; Lymphocele; Sentinel lymph node biopsy

Mesh:

Substances:

Year:  2017        PMID: 29273307     DOI: 10.1016/j.ygyno.2017.12.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  25 in total

1.  The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.

Authors:  Casey M Cosgrove; David E Cohn; Jennifer Rhoades; Ashley S Felix
Journal:  Gynecol Oncol       Date:  2019-03-30       Impact factor: 5.482

Review 2.  Lower extremity lymphedema in patients with gynecologic malignancies.

Authors:  Kimberly Dessources; Emeline Aviki; Mario M Leitao
Journal:  Int J Gynecol Cancer       Date:  2020-01-07       Impact factor: 3.437

3.  Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.

Authors:  Brooke A Schlappe; Amy L Weaver; Jennifer A Ducie; Ane Gerda Zahl Eriksson; Sean C Dowdy; William A Cliby; Gretchen E Glaser; Robert A Soslow; Kaled M Alektiar; Vicky Makker; Nadeem R Abu-Rustum; Andrea Mariani; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2018-08-31       Impact factor: 5.482

4.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

5.  Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer-time to revisit current imaging guidelines?

Authors:  Kristine E Fasmer; Ankush Gulati; Julie A Dybvik; Kari S Wagner-Larsen; Njål Lura; Øyvind Salvesen; David Forsse; Jone Trovik; Johanna M A Pijnenborg; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Eur Radiol       Date:  2022-06-28       Impact factor: 5.315

6.  The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study.

Authors:  Migle Gedgaudaite; Arturas Sukovas; Saulius Paskauskas; Arnoldas Bartusevicius; Vaida Atstupenaite; Eimantas Svedas; Joana Celiesiute; Arvydas Cizauskas; Daiva Vaitkiene; Adrius Gaurilcikas
Journal:  Medicina (Kaunas)       Date:  2022-05-26       Impact factor: 2.948

7.  UPDATE ON SENTINEL LYMPH NODE MAPPING IN ENDOMETRIAL CANCER PATIENTS WITH A HIGH RISK FOR NODAL METASTASIS.

Authors:  Derman Basaran; Mario M Leitao
Journal:  Indian J Gynecol Oncol       Date:  2020-04-13

8.  Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.

Authors:  Mario M Leitao; Qin C Zhou; Natalia R Gomez-Hidalgo; Alexia Iasonos; Ray Baser; Marissa Mezzancello; Kaity Chang; Jae Ward; Dennis S Chi; Kara Long Roche; Yukio Sonoda; Carol L Brown; Jennifer J Mueller; Ginger J Gardner; Elizabeth L Jewell; Vance Broach; Oliver Zivanovic; Sean C Dowdy; Andrea Mariani; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2019-11-25       Impact factor: 5.482

Review 9.  Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.

Authors:  Lirong Zhai; Xiwen Zhang; Manhua Cui; Jianliu Wang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

10.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.